Molecular targets for diabetes mellitus-associated erectile dysfunction

Molecular and Cellular Proteomics

Volumn 9, Issue 3, 2010, Pages 565-578

  Yohannes, Elizabeth ^a   Chang, Jinsook ^a   Tar, Moses T ^b   Davies, Kelvin P ^b   Chance, Mark R ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; COLLAGEN TYPE 1; GLUCOSE; HEAT SHOCK PROTEIN 47; NERVE GROWTH FACTOR; PROCOLLAGEN; PROTEIN 14 3 3; PROTEIN P53; SEX HORMONE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; ERECTILE DYSFUNCTION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; LIPID METABOLISM; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE; UPREGULATION; WESTERN BLOTTING;

14-3-3 PROTEINS; ANIMALS; APOPTOSIS; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; ERECTILE DYSFUNCTION; GONADAL STEROID HORMONES; HSP47 HEAT-SHOCK PROTEINS; HYPERGLYCEMIA; LIPID METABOLISM; MALE; NERVE GROWTH FACTOR; PENIS; PROTEOMICS; RATS; RATS, INBRED F344; STREPTOZOCIN; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; RATTUS;

EID: 77649123864     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M900286-MCP200     Document Type: Article

References (90)

1. Burchardt, T., Burchardt, M., Karden, J., Buttyan, R., Shabsigh, A., de la Taille, A., Ng, P. Y., Anastasiadis, A. G., and Shabsigh, R. (2000) Reduction of endothelial and smooth muscle density in the corpora cavernosa of the streptozotocin induced diabetic rat. J. Urol. 164, 1807-1811
2. Shabsigh, R., Klein, L. T., Seidman, S., Kaplan, S. A., Lehrhoff, B. J., and Ritter, J. S. (1998) Increased incidence of depressive symptoms in men with erectile dysfunction. Urology 52, 848-852
3. Lue, T. F. (2000) Erectile dysfunction. New Engl. J. Med. 342, 1802-1813
4. Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., and McKinlay, J. B. (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J. Urol. 151, 54-61
5. Rosen, R. C., Fisher, W. A., Eardley, I., Niederberger, C., Nadel, A., and Sand, M. (2004) The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr. Med. Res. Opin. 20, 607-617
6. Eardley, I., Fisher, W., Rosen, R. C., Niederberger, C., Nadel, A., and Sand, M. (2007) The multinational Men's Attitudes to Life Events and Sexuality study: the influence of diabetes on self-reported erectile function, attitudes and treatment-seeking patterns in men with erectile dysfunction. Int. J. Clin. Pract. 61, 1446-1453
7. De Berardis, G., Franciosi, M., Belfiglio, M., Di Nardo, B., Greenfield, S., Kaplan, S. H., Pellegrini, F., Sacco, M., Tognoni, G., Valentini, M., and Nicolucci, A. (2002) Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked. Diabetes Care 25, 284-291
8. Penson, D. F., Latini, D. M., Lubeck, D. P., Wallace, K. L., Henning, J. M., and Lue, T. F. (2003) Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database. Diabetes Care 26, 1093-1099
9. Brown, J. S., Wessells, H., Chancellor, M. B., Howards, S. S., Stamm, W. E., Stapleton, A. E., Steers, W. D., Van Den Eeden, S. K., and McVary, K. T. (2005) Urologic complications of diabetes. Diabetes Care 28, 177-185
10. Guay, A. T., Perez, J. B., Jacobson, J., and Newton, R. A. (2001) Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors. J. Androl. 22, 793-797
11. Murray, F. T., Johnson, R. D., Sciadini, M., Katovich, M. J., Rountree, J., and Jewett, H. (1992) Erectile and copulatory dysfunction in chronically diabetic BB/WOR rats. Am. J. Physiol. Endocrinol. Metab. 263, E151-E157
12. Bancroft, J., and Wu, F. C. (1983) Changes in erectile responsiveness during androgen replacement therapy. Arch. Sex. Behav. 12, 59-66
13. Kwan, M., Greenleaf, W. J., Mann, J., Crapo, L., and Davidson, J. M. (1983) The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men. J. Clin. Endocrinol. Metab. 57, 557-562
14. Vernet, D., Cai, L., Garban, H., Babbitt, M. L., Murray, F. T., Rajfer, J., and Gonzalez-Cadavid, N. F. (1995) Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction. Endocrinology 136, 5709-5717
15. McVary, K. T., Rathnau, C. H., and McKenna, K. E. (1997) Sexual dysfunction in the diabetic BB/WOR rat: a role of central neuropathy. Am. J. Physiol. Regul. Integr. Comp. Physiol. 272, R259-R267
16. El-Latif, M. A., Makhlouf, A. A., Moustafa, Y. M., Gouda, T. E., Niederberger, C. S., and Elhanbly, S. M. (2006) Diagnostic value of nitric oxide, lipoprotein(a), and malondialdehyde levels in the peripheral venous and cavernous blood of diabetics with erectile dysfunction. Int. J. Impot. Res. 18, 544-549
17. Prieto, D. (2008) Physiological regulation of penile arteries and veins. Int. J. Impot. Res. 20, 17-29
18. Chitaley, K., Wingard, C. J., Clinton Webb, R., Branam, H., Stopper, V. S., Lewis, R. W., and Mills, T. M. (2001) Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nat. Med. 7, 119-122
19. Farrell, J. B., Deshmukh, A., and Baghaie, A. A. (2008) Low testosterone and the association with type 2 diabetes. Diabetes Educ. 34, 799-806
20. Zhang, X. H., Filippi, S., Morelli, A., Vignozzi, L., Luconi, M., Donati, S., Forti, G., and Maggi, M. (2006) Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. J. Sex. Med. 3, 253-264; discussion 264-265, author reply 265-266
21. Fushimi, H., Horie, H., Inoue, T., Kameyama, M., Kanao, K., Ishihara, S., Tsujimura, T., Nunotani, H., Minami, T., Okazaki, Y., and Tochino, Y. (1989) Low testosterone levels in diabetic men and animals: a possible role in testicular impotence. Diabetes Res. Clin. Pract. 6, 297-301
22. Saenz de Tejada, I., Goldstein, I., Azadzoi, K., Krane, R. J., and Cohen, R. A. (1989) Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. New Engl. J. Med. 320, 1025-1030
23. Cohen, R. A. (2005) Role of nitric oxide in diabetic complications. Am. J. Ther. 12, 499-502
24. Cartledge, J. J., Eardley, I., and Morrison, J. F. (2001) Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes. BJU Int. 87, 402-407
25. Seftel, A. D., Vaziri, N. D., Ni, Z., Razmjouei, K., Fogarty, J., Hampel, N., Polak, J., Wang, R. Z., Ferguson, K., Block, C., and Haas, C. (1997) Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology 50, 1016-1026
26. Bivalacqua, T. J., Hellstrom, W. J., Kadowitz, P. J., and Champion, H. C. (2001) Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem. Biophys. Res. Commun. 283, 923-927
27. Cartledge, J. J., Eardley, I., and Morrison, J. F. (2001) Nitric oxide-mediated corpus cavernosal smooth muscle relaxation is impaired in ageing and diabetes. BJU Int. 87, 394-401
28. Sullivan, M. E., Mumtaz, F. H., Dashwood, M. R., Thompson, C. S., Naseem, K. M., Bruckdorfer, K. R., Mikhailidis, D. P., and Morgan, R. J. (2002) Enhanced relaxation of diabetic rabbit cavernosal smooth muscle in response to nitric oxide: potential relevance to erectile dysfunction. Int. J. Impot. Res. 14, 523-532
29. Kloner, R. A., and Speakman, M. (2002) Erectile dysfunction and atherosclerosis. Curr. Atheroscler. Rep. 4, 397-401
30. Montorsi, P., Ravagnani, P. M., Galli, S., Rotatori, F., Briganti, A., Salonia, A., Dehò, F., and Montorsi, F. (2004) Common grounds for erectile dysfunction and coronary artery disease. Curr. Opin. Urol. 14, 361-365
31. Kapur, V., and Schwarz, E. R. (2007) The relationship between erectile dysfunction and cardiovascular disease. Part I: pathophysiology and mechanisms. Rev. Cardiovasc. Med. 8, 214-219
32. Sullivan, C. J., Teal, T. H., Luttrell, I. P., Tran, K. B., Peters, M. A., and Wessells, H. (2005) Microarray analysis reveals novel gene expression changes associated with erectile dysfunction in diabetic rats. Physiol. Genomics 23, 192-205
33. Hipp, J. D., Davies, K. P., Tar, M., Valcic, M., Knoll, A., Melman, A., and Christ, G. J. (2007) Using gene chips to identify organ-specific, smooth muscle responses to experimental diabetes: potential applications to urological diseases. BJU Int. 99, 418-430
34. Andersson, K. E. (2003) Erectile physiological and pathophysiological pathways involved in erectile dysfunction. J. Urol. 170, S6-S13; discussion S13-S14
35. Rehman, J., Chenven, E., Brink, P., Peterson, B., Walcott, B., Wen, Y. P., Melman, A., and Christ, G. (1997) Diminished neurogenic but not pharmacological erections in the 2- to 3-month experimentally diabetic F-344 rat. Am. J. Physiol. Heart Circ. Physiol. 272, H1960-H1971
36. Christ, G. J., Hsieh, Y., Zhao, W., Schenk, G., Venkateswarlu, K., Wang, H. Z., Tar, M. T., and Melman, A. (2006) Effects of streptozotocin-induced diabetes on bladder and erectile (dys)function in the same rat in vivo. BJU Int. 97, 1076-1082
37. Lilley, K. S., and Friedman, D. B. (2004) All about DIGE: quantification technology for differential-display 2D-gel proteomics. Expert Rev. Proteomics 1, 401-409
38. Alban, A., David, S. O., Bjorkesten, L., Andersson, C., Sloge, E., Lewis, S., and Currie, I. (2003) A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3, 36-44
39. Friedman, D. B., Hill, S., Keller, J. W., Merchant, N. B., Levy, S. E., Coffey, R. J., and Caprioli, R. M. (2004) Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 4, 793-811
40. Friedman, D. B., and Lilley, K. S. (2008) Optimizing the difference gel electrophoresis (DIGE) technology. Methods Mol. Biol. 428, 93-124
41. Marouga, R., David, S., and Hawkins, E. (2005) The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal. Bioanal. Chem. 382, 669-678
42. Yohannes, E., Chang, J., Christ, G. J., Davies, K. P., and Chance, M. R. (2008) Proteomics analysis identifies molecular targets related to diabetes mellitus-associated bladder dysfunction. Mol. Cell. Proteomics 7, 1270-1285
43. Chang, J., Chance, M. R., Nicholas, C., Ahmed, N., Guilmeau, S., Flandez, M., Wang, D., Byun, D. S., Nasser, S., Albanese, J. M., Corner, G. A., Heerdt, B. G., Wilson, A. J., Augenlicht, L. H., and Mariadason, J. M. (2008) Proteomic changes during intestinal cell maturation in vivo. J. Proteomics 71, 530-546
44. Nibbe, R. K., Markowitz, S., Myeroff, L., Ewing, R., and Chance, M. R. (2009) Discovery and scoring of protein interaction subnetworks discriminative of late stage human colon cancer. Mol. Cell. Proteomics 8, 827-845
45. Weissman, B. A., Niu, E., Ge, R., Sottas, C. M., Holmes, M., Hutson, J. C., and Hardy, M. P. (2005) Paracrine modulation of androgen synthesis in rat Leydig cells by nitric oxide. J. Androl. 26, 369-378
46. Zheng, L., Liu, S., Sun, M. Z., Chang, J., Chance, M. R., and Kern, T. S. (2009) Pharmacologic intervention targeting glycolytic-related pathways protects against retinal injury due to ischemia and reperfusion. Proteomics 9, 1869-1882
47. Nikolsky, Y., Ekins, S., Nikolskaya, T., and Bugrim, A. (2005) A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol. Lett. 158, 20-29
48. Mason, C. W., Swaan, P. W., and Weiner, C. P. (2006) Identification of interactive gene networks: a novel approach in gene array profiling of myometrial events during guinea pig pregnancy. Am. J. Obstet. Gynecol. 194, 1513-1523
49. Davies, K. P., Zhao, W., Tar, M., Figueroa, J. C., Desai, P., Verselis, V. K., Kronengold, J., Wang, H. Z., Melman, A., and Christ, G. J. (2007) Diabetes-induced changes in the alternative splicing of the slo gene in corporal tissue. Eur. Urol. 52, 1229-1237
50. Shevchenko, A., Wilm, M., Vorm, O., and Mann, M. (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68, 850-858
51. Bennett, R. A., and Pegg, A. E. (1981) Alkylation of DNA in rat tissues following administration of streptozotocin. Cancer Res. 41, 2786-2790
52. Yaman, O., Yilmaz, E., Bozlu, M., and Anafarta, K. (2003) Alterations of intracorporeal structures in patients with erectile dysfunction. Urol. Int. 71, 87-90
53. Salama, N., and Kagawa, S. (1999) Ultra-structural changes in collagen of penile tunica albuginea in aged and diabetic rats. Int. J. Impot. Res. 11, 99-105
54. Nagata, K. (2003) HSP47 as a collagen-specific molecular chaperone: function and expression in normal mouse development. Semin. Cell Dev. Biol. 14, 275-282
55. Nagata, K. (1996) Hsp47: a collagen-specific molecular chaperone. Trends Biochem. Sci. 21, 22-26
56. Rocnik, E. F., van der Veer, E., Cao, H., Hegele, R. A., and Pickering, J. G. (2002) Functional linkage between the endoplasmic reticulum protein Hsp47 and procollagen expression in human vascular smooth muscle cells. J. Biol. Chem. 277, 38571-38578
57. Liu, D., Razzaque, M. S., Cheng, M., and Taguchi, T. (2001) The renal expression of heat shock protein 47 and collagens in acute and chronic experimental diabetes in rats. Histochem. J. 33, 621-628
58. Razzaque, M. S., Kumatori, A., Harada, T., and Taguchi, T. (1998) Coexpression of collagens and collagen-binding heat shock protein 47 in human diabetic nephropathy and IgA nephropathy. Nephron 80, 434-443
59. Ohashi, S., Abe, H., Takahashi, T., Yamamoto, Y., Takeuchi, M., Arai, H., Nagata, K., Kita, T., Okamoto, H., Yamamoto, H., and Doi, T. (2004) Advanced glycation end products increase collagen-specific chaperone protein in mouse diabetic nephropathy. J. Biol. Chem. 279, 19816-19823
60. Wang, T. Y., Chamberlin, L. L., and Xu, Y. H. (1986) Characterization of the androgen-dependent 22Kdalton glycoprotein from rat ventral prostate. J. Steroid Biochem. 24, 929-932
61. Chamberlin, L. L., Mpanias, O. D., and Wang, T. Y. (1983) Isolation, properties, and androgen regulation of a 20-kilodalton protein from rat ventral prostate. Biochemistry 22, 3072-3077
62. Devos, A., Claessens, F., Alen, P., Winderickx, J., Heyns, W., Rombauts, W., and Peeters, B. (1997) Identification of a functional androgen-response element in the exon 1-coding sequence of the cystatin-related protein gene crp2. Mol. Endocrinol. 11, 1033-1043
63. Winderickx, J., Hemschoote, K., De Clercq, N., Van Dijck, P., Peeters, B., Rombauts, W., Verhoeven, G., and Heyns, W. (1990) Tissue-specific expression and androgen regulation of different genes encoding rat prostatic 22-kilodalton glycoproteins homologous to human and rat cystatin. Mol. Endocrinol. 4, 657-667
64. Vanaken, H., Claessens, F., Vercaeren, I., Heyns, W., Peeters, B., and Rombauts, W. (1996) Androgenic induction of cystatin-related protein and the C3 component of prostatic binding protein in primary cultures from the rat lacrimal gland. Mol. Cell. Endocrinol. 121, 197-205
65. Vercaeren, I., Vanaken, H., Devos, A., Peeters, B., Verhoeven, G., and Heyns, W. (1996) Androgens transcriptionally regulate the expression of cystatin-related protein and the C3 component of prostatic binding protein in rat ventral prostate and lacrimal gland. Endocrinology 137, 4713-4720
66. Roy, A. K., and Leonard, S. (1973) Androgen-dependent synthesis of 2u globulin in diabetic rats: the role of insulin. J. Endocrinol. 57, 327-328
67. Murty, C. V., Rao, K. V., and Roy, A. K. (1987) Rapid androgenic stimulation of alpha 2u-globulin synthesis in the perfused rat liver. Endocrinology 121, 1814-1818
68. Gubits, R. M., Lynch, K. R., Kulkarni, A. B., Dolan, K. P., Gresik, E. W., Hollander, P., and Feigelson, P. (1984) Differential regulation of alpha 2u globulin gene expression in liver, lachrymal gland, and salivary gland. J. Biol. Chem. 259, 12803-12809
69. Böcskei, Z., Groom, C. R., Flower, D. R., Wright, C. E., Phillips, S. E., Cavaggioni, A., Findlay, J. B., and North, A. C. (1992) Pheromone binding to two rodent urinary proteins revealed by X-ray crystallography. Nature 360, 186-188
70. Traish, A., and Kim, N. (2005) The physiological role of androgens in penile erection: regulation of corpus cavernosum structure and function. J. Sex. Med. 2, 759-770
71. Reilly, C. M., Zamorano, P., Stopper, V. S., and Mills, T. M. (1997) Androgenic regulation of NO availability in rat penile erection. J. Androl. 18, 110-115
72. Park, J., Kwon, H., Kang, Y., and Kim, Y. (2007) Proteomic analysis of O-GlcNAc modifications derived from streptozotocin and glucosamine induced beta-cell apoptosis. J. Biochem. Mol. Biol. 40, 1058-1068
73. Ho, T. C., Chen, S. L., Yang, Y. C., Liao, C. L., Cheng, H. C., and Tsao, Y. P. (2007) PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells. Cardiovasc. Res. 76, 213-223
74. Jazayeri, L., Callaghan, M. J., Grogan, R. H., Hamou, C. D., Thanik, V., Ingraham, C. R., Capell, B. C., Pelo, C. R., and Gurtner, G. C. (2008) Diabetes increases p53-mediated apoptosis following ischemia. Plast. Reconstr. Surg. 121, 1135-1143
75. Allen, D. A., Yaqoob, M. M., and Harwood, S. M. (2005) Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J. Nutr. Biochem. 16, 705-713
76. Ryan, A., Murphy, M., Godson, C., and Hickey, F. B. (2009) Diabetes mellitus and apoptosis: inflammatory cells. Apoptosis 14, 1435-1450
77. Xie, D., Odronic, S. I., Wu, F., Pippen, A., Donatucci, C. F., and Annex, B. H. (2007) Mouse model of erectile dysfunction due to diet-induced diabetes mellitus. Urology 70, 196-201
78. Rajagopalan, S., Jaulent, A. M., Wells, M., Veprintsev, D. B., and Fersht, A. R. (2008) 14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers. Nucleic Acids Res. 36, 5983-5991
79. Komarova, E. A., Diatchenko, L., Rokhlin, O. W., Hill, J. E., Wang, Z. J., Krivokrysenko, V. I., Feinstein, E., and Gudkov, A. V. (1998) Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53. Oncogene 17, 1089-1096
80. Fani, K., Lundin, A. P., Beyer, M. M., Jimenez, F. A., and Friedman, E. A. (1983) Pathology of the penis in long-term diabetic rats. Diabetologia 25, 424-428
81. Nakamura, K., Yamagishi, S., Adachi, H., Kurita-Nakamura, Y., Matsui, T., and Inoue, H. (2009) Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes. Diabetes Metab. Res. Rev. 25, 52-56
82. Jenkins, A., Zhang, S. X., Gosmanova, A., Aston, C., Dashti, A., Baker, M. Z., Lyons, T., and Ma, J. X. (2008) Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients. Diabetes Res. Clin. Pract. 82, e5-e7
83. Van Lenten, B. J., Wagner, A. C., Jung, C. L., Ruchala, P., Waring, A. J., Lehrer, R. I., Watson, A. D., Hama, S., Navab, M., Anantharamaiah, G. M., and Fogelman, A. M. (2008) Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I. J. Lipid Res. 49, 2302-2311
84. Culnan, D. M., Cooney, R. N., Stanley, B., and Lynch, C. J. (2009) Apolipoprotein A-IV, a putative satiety/antiatherogenic factor, rises after gastric bypass. Obesity 17, 46-52
85. O'Looney, P., Irwin, D., Briscoe, P., and Vahouny, G. V. (1985) Lipoprotein composition as a component in the lipoprotein clearance defect in experimental diabetes. J. Biol. Chem. 260, 428-432
86. Kim, S. W., Hwang, H. J., Kim, H. M., Lee, M. C., Shik Lee, M., Choi, J. W., and Yun, J. W. (2006) Effect of fungal polysaccharides on the modulation of plasma proteins in streptozotocin-induced diabetic rats. Proteomics 6, 5291-5302
87. Gianazza, E., Eberini, I., Villa, P., Fratelli, M., Pinna, C., Wait, R., Gemeiner, M., and Miller, I. (2002) Monitoring the effects of drug treatment in rat models of disease by serum protein analysis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 771, 107-130
88. Fujita, T., Suzuki, K., Tada, T., Yoshihara, Y., Hamaoka, R., Uchida, K., Matuo, Y., Sasaki, T., Hanafusa, T., and Taniguchi, N. (1998) Human erythrocyte bisphosphoglycerate mutase: inactivation by glycation in vivo and in vitro. J. Biochem. 124, 1237-1244
89. Sasaki, K., Chancellor, M. B., Goins, W. F., Phelan, M. W., Glorioso, J. C., de Groat, W. C., and Yoshimura, N. (2004) Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy. Diabetes 53, 2723-2730
90. Dahiya, R., Chui, R., Perinchery, G., Nakajima, K., Oh, B. R., and Lue, T. F. (1999) Differential gene expression of growth factors in young and old rat penile tissues is associated with erectile dysfunction. Int. J. Impot. Res. 11, 201-206